Polycystic ovary syndrome (PCOS) affects more than 7 million women across the globe. Among other symptoms of oligo/anovulation, clinical and/or biochemical evidence of androgen excess, obesity, PCOS is also characterized by insulin resistance.

Metformin has been explored as one of the well-established oral insulin-sensitizing agents concerning its applicability for women with PCOS. In the following survey, we intend to gain insights about your general view on PCOS management.